Warburg Pincus Capital Corporation I-B
WPCB
New York Stock Exchange10.21
USD
+0.01
- -
CIK
0001836074
CUSIP
G9460M108
Return %
Stock
S&P500
1Y
4.08
26.53
3Y
4.18
76.60
5Y
4.18
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Christopher H. Turner
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 450 Lexington Avenue New York City NY United States of America 10017
- CIK
- 0001836074
- Website
- warburgpincuscapitalcorp.com
- Similar Companies
- Business
- Warburg Pincus Capital Corporation I-B (WPCB) operates as a blank check company, or special purpose acquisition company (SPAC), whose principal business activity is to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It targets companies with strong fundamental growth potential, particularly in subspecialties including financial technology (FinTech); cybersecurity; education technology (EdTech); payments; information services; tech-enabled supply chain and logistics; regulatory compliance; and healthcare information technology (HCIT), without current significant operations or revenue generation. Sponsored by Warburg Pincus LLC, a leading global private equity firm founded in 1966 and headquartered at 450 Lexington Avenue in New York, the SPAC was incorporated on December 1, 2020, raised $500 million in its initial public offering priced on March 3, 2021, and trades on the New York Stock Exchange with units comprising one Class A ordinary share and one-fifth of one redeemable warrant. As of late 2025, Warburg Pincus Capital Corporation I-B remains pre-combination with no announced merger target or de-SPAC transaction within the standard two-year timeframe post-IPO, amid extended market conditions for SPACs; meanwhile, its sponsor Warburg Pincus LLC has pursued major strategic expansions including leading a C$1.9 billion all-cash acquisition consortium for ECN Capital Corp. announced in November 2025 and entering exclusive negotiations in October 2025 for a significant minority stake in diagnostics leader Sebia from CVC Funds and other shareholders. The SPAC focuses on U.S. and potentially global target markets aligned with sponsor expertise across financial services, healthcare, technology, and industrials.